LIOTON

This brand name is authorized in Austria, Cyprus, Estonia, Hong Kong, Croatia, Lithuania, Malta, Poland, Romania

Active ingredients

The drug LIOTON contains one active pharmaceutical ingredient (API):

1 Heparin UNII ZZ45AB24CA - HEPARIN SODIUM

Heparin is an anticoagulant and acts by inhibiting thrombin and by potentiating the naturally occurring inhibitors of activated Factor X (Xa). Read about Heparin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LIOTON Gel	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C05BA03	Heparin	C Cardiovascular system → C05 Vasoprotectives → C05B Antivaricose therapy → C05BA Heparins or heparinoids for topical use
Discover more medicines within C05BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1014578, 1071784, 1269042
Country: HK	Department of Health Drug Office	Identifier(s): 25113
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-931918675
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1006530, 1006531, 1024093
Country: MT	Medicines Authority	Identifier(s): MA205/00201
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100080800
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W03453001, W03453002, W03453003, W03453004